Inherent single-cell heterogeneity of the transcriptional response to hypoxia in cancer cells
NAR Cancer · 2025
DOI: 10.1093/narcan/zcaf021 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Cancer, 2025. Verfasst von Małgorzata Wilk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, University of Zürich, Zürich, CH-8057, Switzerland. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Single-Cell Analysis, Hypoxia-Inducible Factor 1, alpha Subunit, Neoplasms. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
Hypoxia-inducible factor (HIF) is a master regulator of cancer cell adaptation to tumor hypoxia and is involved in cancer progression. Single-cell (sc) differences in the HIF response allow for tumor evolution and cause therapy resistance. These sc-differences are usually ascribed to tumor microenvironmental differences and/or clonal (epi)genetic variability. However, the sc-heterogeneity of the HIF response in otherwise identical cells cultured under defined in vitro conditions has not yet been addressed. Therefore, we analyzed the sc-response to hypoxia in nonclonal cell lines and multiple clonal derivatives, including HIF-1α or HIF-2α knockouts. While HIF-1α and HIF-1 target mRNA sc-heterogeneity was slightly higher than global transcription or specific housekeeping messenger RNAs (mRNAs), HIF-2α and especially HIF-2 target mRNA sc-heterogeneity was extraordinary, and remained in independent clones following HIFα knockouts. Unexpectedly, neither HIF-2α mRNA nor nuclear protein levels correlated with target mRNA levels. Unsupervised but not supervised HIF target gene dimensionality reduction revealed the initial sample composition after scRNA-seq, demonstrating that, owing to sc-heterogeneity, individual HIF target genes are not sufficient to unequivocally identify hypoxic cancer cells. In conclusion, the pronounced intrinsic sc-heterogeneity of the HIF response represents a hitherto unrecognized feature of cancer cells that impairs clinical HIF pathway-dependent cancer cell identification and targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Physiology, University of Zürich, Zürich, CH-8057, Switzerland.
ORCID-Profile: Roland H Wenger
Förderung
- Swiss National Science Foundation
Zitieren
APA
Wilk, M., Knöpfel, T., Burger, S. M., Khodo, S. N., & Wenger, R. H. (2025). Inherent single-cell heterogeneity of the transcriptional response to hypoxia in cancer cells. NAR Cancer. https://doi.org/10.1093/narcan/zcaf021
Vancouver
Wilk M, Knöpfel T, Burger SM, Khodo SN, Wenger RH. Inherent single-cell heterogeneity of the transcriptional response to hypoxia in cancer cells. NAR Cancer. 2025. doi:10.1093/narcan/zcaf021
BibTeX
@article{Wilk2025,
author = {Wilk, Małgorzata and Knöpfel, Thomas and Burger, Stana M and Khodo, Stellor Nlandu and Wenger, Roland H},
title = {Inherent single-cell heterogeneity of the transcriptional response to hypoxia in cancer cells},
journal = {NAR Cancer},
year = {2025},
doi = {10.1093/narcan/zcaf021}
}
EUVIMED